Abstract
Background: The prevalence and scope of dermatological illness differ from region to region. Based upon type and severity, the conditions may vary from superficial to deep systemic skin infections. Niacinamide, an amide analog of vitamin B3 which was conventionally utilized as a food supplement, is now explored for the management of skin disorders. Being a powerhouse on its own, it is not stored inside the body naturally and has to be acquired from external sources.
Areas Covered: This review is an attempt to disclose the physiology, pharmacology, and highlight the dermatological potentials of niacinamide, discussing its pharmacological mechanisms, varied commercially available treatments, and novel approaches, i.e., in research and patented formulations.
Results: Niacinamide has been verified in treating almost every skin disorder, viz. aging, hyperpigmentation, acne, psoriasis, pruritus, dermatitis, fungal infections, epidermal melasma, non-melanoma skin cancer, etc. It has been reported to possess numerous properties, for instance, anti-inflammatory, antimicrobial, antioxidant, antipruritic, and anticancer, which makes it an ideal ingredient for varied dermal therapies. Long term use of niacinamide, regardless of the skin type, paves the way for new skin cells, making skin healthier, brighter, and hydrated.
Conclusion: Niacinamide possesses a variety of positive characteristics in the field of dermatology. Novel approaches are warranted over current treatments which could bypass the above shortcomings and form an effective and stable system. Hence, niacinamide has the potential to become an individual and a productive component with wide future scope.
Keywords: Co-crystals, dermatological disorders, nanoparticles, niacinamide, non-melanoma skin cancer, patents.
Graphical Abstract
[http://dx.doi.org/10.1111/ced.13021] [PMID: 28052374]
[http://dx.doi.org/10.1111/jocd.12119] [PMID: 25399625]
[http://dx.doi.org/10.1111/ajd.12163] [PMID: 24635573]
[http://dx.doi.org/10.1111/j.1467-2494.2004.00228.x] [PMID: 18492135]
[http://dx.doi.org/10.3390/pharmaceutics12050472] [PMID: 32455797]
[http://dx.doi.org/10.1111/j.1467-2494.2005.00266.x] [PMID: 18492206]
[http://dx.doi.org/10.1159/000359974] [PMID: 24993939]
[http://dx.doi.org/10.1586/edm.09.68]
[http://dx.doi.org/10.3389/fmicb.2019.00595] [PMID: 30972047]
[http://dx.doi.org/10.3389/fmicb.2016.01238] [PMID: 27547205]
[http://dx.doi.org/10.1038/nm.2175] [PMID: 20601951]
[http://dx.doi.org/10.1172/JCI62070] [PMID: 22922257]
[http://dx.doi.org/10.1016/j.jaci.2006.11.634] [PMID: 17336614]
[http://dx.doi.org/10.4103/ijdvl.IJDVL_286_17] [PMID: 29405129]
[http://dx.doi.org/10.3390/biom10030477] [PMID: 32245130]
[http://dx.doi.org/10.1089/10966200152053686] [PMID: 12639285]
[http://dx.doi.org/10.1159/000366550] [PMID: 25561219]
[PMID: 10097894]
[PMID: 16596767]
[http://dx.doi.org/10.1111/j.1742-481X.2012.01052.x] [PMID: 22892041]
[http://dx.doi.org/10.3390/antiox10081315] [PMID: 34439563]
[http://dx.doi.org/10.4103/0378-6323.58674] [PMID: 20061726]
[PMID: 26682557]
[http://dx.doi.org/10.3109/10837450.2014.971378] [PMID: 25318786]
[http://dx.doi.org/10.22377/ajp.v12i01.2050]
[http://dx.doi.org/10.22159/ijap.2017.v9s1.39_45]
[http://dx.doi.org/10.1002/jps.24048] [PMID: 24903146]
[http://dx.doi.org/10.5530/ijper.53.4s.151]
[http://dx.doi.org/10.3390/scipharm86020023] [PMID: 29867030]
[http://dx.doi.org/10.3109/10717541003587418] [PMID: 20163194]
[http://dx.doi.org/10.1002/ffj.1093]
[http://dx.doi.org/10.2147/IJN.S16815] [PMID: 21674018]
[PMID: 31251546]
[http://dx.doi.org/10.1111/jdv.13851] [PMID: 27545662]
[http://dx.doi.org/10.1146/annurev.pc.43.100192.002013]
[http://dx.doi.org/10.1080/01932699708943740]
[http://dx.doi.org/10.1021/cr00036a003]
[http://dx.doi.org/10.1021/ar00151a001]
[http://dx.doi.org/10.1002/anie.201005159] [PMID: 21626614]
[http://dx.doi.org/10.1002/adma.200703183]
[http://dx.doi.org/10.1016/S0021-8502(97)10037-4]
[http://dx.doi.org/10.4103/0250-474X.57283] [PMID: 20502540]
[http://dx.doi.org/10.13005/msri/140103]
[http://dx.doi.org/10.1039/b505883j]
[http://dx.doi.org/10.1107/S0108767308099637]
[http://dx.doi.org/10.1002/jps.20578] [PMID: 16444755]
[http://dx.doi.org/10.1016/j.proche.2014.10.079]
[http://dx.doi.org/10.22270/jddt.v8i6-s.2194]
[http://dx.doi.org/10.1021/acs.cgd.8b00933]
[http://dx.doi.org/10.15272/ajbps.v5i47.713]